Literature DB >> 12740642

Expression of p65, DD3 and c-erbB2 genes in prostate cancer.

E Balcerczak1, M Mirowski, A Sasor, R Wierzbicki.   

Abstract

The expression of p65, DD3 and c-erbB2 genes was analyzed in 39 histologically verified human prostate cancers. The expression of p65 and DD3 genes was observed in significant percentage in well- and moderately-differentiated tumors. Both genes expression was lower in poorly differentiated tumors. On the contrary, c-erbB2 gene expression increased with advanced histological grading and reached the highest percentage in poorly-differentiated cancers. In the all investigated groups straight dependence between p65 and DD3 genes expression occurred. Opposite dependence was noticed in expression of p65/DD3 and c-erbB2 genes.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12740642

Source DB:  PubMed          Journal:  Neoplasma        ISSN： 0028-2685            Impact factor:   2.575


  3 in total

Review 1.  Trends in Gene Expression Profiling for Prostate Cancer Risk Assessment: A Systematic Review.

Authors:  Zhaoyi Chen; Travis Gerke; Victoria Bird; Mattia Prosperi
Journal:  Biomed Hub       Date:  2017-05-17

2.  Quantitative analysis of the p65 gene expression in patients with coloroctal cancer.

Authors:  E Balcerczak; M Balcerczak; M Mirowski
Journal:  Int J Biomed Sci       Date:  2007-12

3.  Differentially expressed androgen-regulated genes in androgen-sensitive tissues reveal potential biomarkers of early prostate cancer.

Authors:  Dogus Murat Altintas; Nathalie Allioli; Myriam Decaussin; Simon de Bernard; Alain Ruffion; Jacques Samarut; Virginie Vlaeminck-Guillem
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.